Hot Healthcare Equipment Stocks To Watch For 2014

The Q1 2014 earnings report for the Bon-Ton Stores, Inc (NASDAQ: BONT), a peer of other department store stocks like J.C. Penney Company, Inc (NYSE: JCP), Kohl's Corporation (NYSE: KSS) and Sears Holdings Corp (NASDAQ: SHLD), is due out before the market opens on Thursday. Aside from the Bon-Ton Stores' earnings report, it should be said that troubled Sears Holdings Corp is also scheduled to report earnings before the market opens on Thursday while J.C. Penney Company, Inc�and Kohl's Corporation both reported Q1 2014 earnings last Thursday. However, the Bon-Ton Stores is heading into earnings with rather high short interest of 35.05% according to HighShortInterest.com.

What Should You Watch Out for With the Bon-Ton Stores, Inc Earnings Report?

First, here is a quick recap of Bon-Ton Stores��recent earnings history from Yahoo! Finance:

Best Communications Equipment Stocks To Buy For 2015: Maiden Hldgs Ltd(MHLD)

Maiden Holdings, Ltd., through its subsidiaries, provides reinsurance solutions to regional and specialty insurers primarily in the United States and Europe. The company offers property, casualty, accident, and health reinsurance products. It offers its products through the treaties with other insurers on a quota share or excess of loss basis, as well as on a facultative basis through third-party intermediaries and on direct basis. Maiden Holdings, Ltd. was founded in 2007 and is headquartered Hamilton, Bermuda.

Advisors' Opinion:

• [By Marc Bastow]

  Bermuda-based reinsurance solutions provider Maiden Holdings (MHLD) raised its quarterly dividend 22% to 11 cents per share, payable on Jan. 15 to shareholders of record as of Jan. 2.
  MHLD Dividend Yield: 3.79%
  

Hot Healthcare Equipment Stocks To Watch For 2014: United Stationers Inc.(USTR)

United Stationers Inc., through its subsidiary, United Stationers Supply Co., engages in the wholesale distribution of business products in North America. The company distributes technology products, which include computer supply and peripheral products, including imaging supplies, data storage, digital cameras, computer accessories, and computer hardware items. It also offers traditional office products consisting of brand-name and private label office supply products, such as filing and record storage products, business machines, presentation products, writing instruments, paper products, shipping and mailing supplies, calendars, and general office accessories; and office furniture products comprising desks, filing and storage solutions, and seating and systems furniture. In addition, the company distributes janitorial and breakroom supply items, including cleaners and cleaning accessories; foodservice consumables, such as disposable cups, plates, and utensils; safety an d security items; and paper and packaging supplies. Further, it provides industrial supply items, such as hand and power tools; safety and security supplies; janitorial equipment and supplies; industrial maintenance, repair, and operations (MRO) items; and oil field and welding supplies. Additionally, the company offers freight, advertising, and software services, as well as sells software products. It serves independent office products dealers; contract stationers; office products superstores; computer products resellers; office furniture dealers; mass merchandisers; mail order companies; sanitary supply, paper, and foodservice distributors; drug and grocery store chains; healthcare distributors; e-commerce merchants; oil field, welding supply, and industrial/MRO distributors; and other independent distributors through its network of 65 distribution centers and 37 re-distribution points. United Stationers Inc. was founded in 1922 and is headquartered in Deerfield, Illinois.

Advisors' Opinion:

• [By Seth Jayson]

  Calling all cash flows
  When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on United Stationers (Nasdaq: USTR  ) , whose recent revenue and earnings are plotted below.

• [By Holly LaFon]

  The company�� primarily competitors are Office Depot (ODP), United Stationers (USTR) and Office Max (OMX). Staples has the best gross margins of its competitors, at greater than 26%, and the only one to increase its book value per share since 2001.

• [By Monica Gerson]

  United Stationers (NASDAQ: USTR) is projected to post its Q3 earnings at $0.99 per share on revenue of $1.33 billion.

  Wynn Resorts (NASDAQ: WYNN) is estimated to post its Q3 earnings at $1.65 per share on revenue of $1.36 billion.

Hot Healthcare Equipment Stocks To Watch For 2014: Xcel Energy Inc.(XEL)

Xcel Energy Inc., through its subsidiaries, engages in the generation, purchase, transmission, distribution, and sale of electricity to residential, commercial, and industrial customers, as well as to public authorities in the United States. The company generates electricity using coal, nuclear, natural gas, hydro, wood, diesel, and wind energy. It also engages in the purchase, transportation, distribution, and sale of natural gas to residential, commercial, and industrial customers. The company serves customers in portions of Colorado, Michigan, Minnesota, New Mexico, North Dakota, South Dakota, Texas, and Wisconsin. As of December 31, 2010, it provided electricity services to 3,391,611 customers; and natural gas services to 1,893,250 customers. Xcel Energy, through its joint venture interests in WYCO Development LLC, develops and leases natural gas pipeline, storage, and compression facilities. The company was founded in 1909 and is based in Minneapolis, Minnesota.

Advisors' Opinion:

• [By David Dittman]

  Answer: I like Northeast Utilities (NYSE: NU), Brookfield Renewable Energy Partners LP (TSX: BEP-U, NYSE: BEP), Pembina Pipeline Corp (TSX: PPL, NYSE: PBA), Xcel Energy Inc (NYSE: XEL) and NiSource Inc (NYSE: NI).

• [By Rich Smith]

  Schadenfreude's in season
  Not everyone's opposed to the law, necessarily. For example, Xcel Energy (NYSE: XEL  ) is already working to expand its portfolio of wind-generated power in the state, and two years ago, it put into operation a 19-megawatt solar farm in cooperation with SunPower (NASDAQ: SPWR  ) . As a so-called "investor-owned utility," Xcel is already subject to a target of 30% renewables use by 2020 -- so a law making its rural rivals hit a 20% target probably didn't upset Xcel all that much.

• [By David Dittman]

  Answer: It’s too soon to say what the financial impact of the Winnipeg incident will have on TransCanada. The impact for its customers, including Xcel Energy (NYSE: XEL) and Great Plains Energy (NYSE: GXP), may be more acute in the short term. TransCanada will definitely be under increased regulatory scrutiny.
  I’m a fan of TransCanada for the long term. It has a solid, diverse and growing presence in North American energy infrastructure. It’s about much more than Keystone XL.

• [By Shauna O'Brien]

  Jefferies announced on Wednesday that it has raised its rating on Xcel Energy Inc (XEL).

  The firm has upgraded XEL from “Hold” to “Buy,” and has raised the company’s price target from $31 to $32.50. This new price target suggests a 15% upside from the stock’s current price of $27.72.

  Analyst Paul B. Fremont commented: “The stock is currently trading at an 8% P/E discount to our 2015E group average multiple.”

  “Despite a difficult political environment in Minnesota the company was able to achieve a reasonable outcome in its NSP-Minnesota rate case,” the analyst added.

  Looking forward, the firm has increased its FY2014 outlook from $1.95 to $2.00 per share.

  Xcel Energy shares were mostly flat during pre-market trading Wednesday. The stock has been mostly flat YTD.

Hot Healthcare Equipment Stocks To Watch For 2014: Peregrine Pharmaceuticals Inc.(PPHM)

Peregrine Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, engages in the research and development of monoclonal antibodies for the treatment of cancer and viral infections. Its products under development include bavituximab, a phosphatidylserine-targeting antibody, which is in Phase II trials for the treatment of front-line and second-line non-small cell lung cancer (NSCLC), and pancreatic cancer; and Cotara, a DNA/histone-targeting antibody that is in Phase II trial for the treatment of recurrent glioblastoma multiforme. The company is also developing bavituximab in combination with ribavirin, which is in Phase II clinical trial for the treatment of patients with genotype-1 hepatitis C virus infection. In addition, it has investigator-sponsored trial programs that evaluate bavituximab for the treatment of patients with liver cancer, second-line castration resistant prostate cancer, HER-2 negative metastatic breast cancer, and locally advanced or metasta tic NSCLC. Further, the company, through its wholly-owned subsidiary, Avid Bioservices, Inc., provides integrated current Good Manufacturing Practices (cGMP) commercial and clinical manufacturing services in the United States, including contract manufacturing of antibodies, recombinant proteins, and enzymes; cell culture development; process development; and testing of biologics for biopharmaceutical and biotechnology companies under cGMP. It has licensing agreements with the University of Texas Southwestern Medical Center; Merck KGaA; SuperGen, Inc.; and Affitech A/S. Peregrine Pharmaceuticals, Inc. intends to sell its products in the United States and internationally in collaboration with marketing partners or through a direct sales force. The company was founded in 1981 and is based in Tustin, California.

Advisors' Opinion:

• [By Sean Williams]

  Also gaining double digits on the week was the highly embattled Peregrine Pharmaceuticals (NASDAQ: PPHM  ) which rallied after the FDA approved its late-stage trial design for its second-line non-small-cell lung cancer immunotherapy, Bavituximab. While trial design approvals are rarely big news, it is in this case because mid-stage results for Bavituximab have been all over the place. At first Bavituximab demonstrated a better than doubling in progression-free survival followed weeks later by management's insistence that investors were not to trust the data. A few months later, following a review, we were told to trust the data again. This filing helps relieve some of the confusion surrounding Peregrine's mid-stage results, and hopefully its phase 3 study will be black-and-white obvious as to whether Bavituximab provides a statistically significant benefit.

• [By Tom Bemis]

  Few major companies are reporting after Monday�� bell. Results are expected from Destiny Media Technologies (DSNY) �, Stanley Furniture Co. (STLY) � and Peregrine Pharmaceuticals. (PPHM) �.

• [By Sean Williams]

  What: Shares of Peregrine Pharmaceuticals (NASDAQ: PPHM  ) , a biopharmaceutical company developing monoclonal antibodies to treat cancer, jumped as much as 19% after the company reported final data on its mid-stage second-line non-small cell lung cancer drug, Bavituximab, at the annual American Society of Clinical Oncology meeting.

Hot Healthcare Equipment Stocks To Watch For 2014: Martin Marietta Materials Inc. (MLM)

Martin Marietta Materials, Inc., together with its subsidiaries, engages in the production and sale of aggregates for the construction industry primarily in the United States, Canada, the Bahamas, and the Caribbean Islands. The company operates in four segments: Mideast Group, Southeast Group, West Group, and Specialty Products. It mines, processes, and sells granite, limestone, sand, gravel, and other aggregate products for use in the public infrastructure, and nonresidential and residential construction industries, as well as in the agriculture, railroad ballast, chemical, and other applications. The company also offers asphalt, ready mixed concrete, and road paving materials. In addition, it manufactures and markets magnesia-based chemical products for the industrial, agricultural, and environmental applications; and dolomitic lime primarily for use in the steel industry. These chemical products are used in flame retardants, wastewater treatment, pulp and paper producti on, and other environmental applications. Martin Marietta Materials, Inc. was founded in 1993 and is based in Raleigh, North Carolina.

Advisors' Opinion:

• [By MONEYMORNING]

  Too bad Einhorn's next slide was Martin Marietta Materials Inc. (NYSE: MLM), whose stock symbol happens to be MLM...

  Oops! The crowd, also expecting the idea to be shorting Herbalife, turned heel and sent out orders from the conference to cover their Herbalife shorts. The stock rose on the day.

• [By Ben Levisohn]

  Shares of Vulcan have gained 7.6%, and given a lift to other cement makers today, including Martin Marietta Materials (MLM), which has risen 4.9% and reports earnings on Thursday, Cemex (CX), which has advanced 1.5%, and Texas Industries (TXI), which is up 4.9%.

• [By Dan Caplinger]

  Still, most companies in the space have high expectations for the future. Martin Marietta Materials (NYSE: MLM  ) said in its first-quarter report that it expects rising shipments for its aggregates, pointing to better housing starts, employment figures in the construction industry, and the need to upgrade highways as justifying greater sales.

• [By Anna Prior]

  Martin Marietta Materials Inc.(MLM) will replace United States Steel Corp.(X) (X) in the Standard and Poor’s 500-stock index after the market closes July 1, according to S&P.

Hot Healthcare Equipment Stocks To Watch For 2014: Cadence Pharmaceuticals Inc.(CADX)

Cadence Pharmaceuticals, Inc., a biopharmaceutical company, focuses on acquiring, in-licensing, developing, and commercializing proprietary product candidates principally for use in the hospital setting in the United States and Canada. It holds rights to OFIRMEV injection, a proprietary intravenous formulation of acetaminophen for the management of pain and reduction of fever in adults and children. The company in-licenses rights to OFIRMEV from Bristol-Myers Squibb Company, which sells intravenous acetaminophen in Europe and other markets for the treatment of acute pain and fever under the Perfalgan brand name. Cadence Pharmaceuticals, Inc. was founded in 2004 and is headquartered in San Diego, California.

Advisors' Opinion:

• [By Paul Ausick]

  Stocks on the Move: Zulily Inc. (NASDAQ: ZU) is up 71.4% at $37.70 after its IPO today. Cadence Pharmaceuticals Inc. (NASDAQ: CADX) is up 33.8% at $7.87 on a patent ruling. Electronic Arts Inc. (NASDAQ: EA) is down 7.4% at $24.04.

• [By Jake L'Ecuyer]

  Equities Trading UP
  Cadence Pharmaceuticals (NASDAQ: CADX) shot up 26.42 percent to $14.02 after Mallinckrodt plc (NYSE: MNK) announced its plans to acquire Cadence Pharma for $14.00 per share in cash.